These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with a combination of pharmacological agents based on rectal non-steroidal anti-inflammatory drugs: A systematic review and network meta-analysis. Oh HC; Kang H; Park TY; Choi GJ; Lehman GA J Gastroenterol Hepatol; 2021 Jun; 36(6):1403-1413. PubMed ID: 33068012 [TBL] [Abstract][Full Text] [Related]
5. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography. Thiruvengadam NR; Forde KA; Ma GK; Ahmad N; Chandrasekhara V; Ginsberg GG; Ho IK; Jaffe D; Panganamamula KV; Kochman ML Gastroenterology; 2016 Aug; 151(2):288-297.e4. PubMed ID: 27215656 [TBL] [Abstract][Full Text] [Related]
6. The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis. Ahmad D; Lopez KT; Esmadi MA; Oroszi G; Matteson-Kome ML; Choudhary A; Bechtold ML Pancreas; 2014 Apr; 43(3):338-42. PubMed ID: 24622061 [TBL] [Abstract][Full Text] [Related]
7. Take 2 Indomethacin (Suppositories) and Call Me in the Morning? The Role of Nonsteroidal Anti-inflammatory Drugs in Protection Against Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Freeman ML; Kozarek RA Gastroenterology; 2016 Apr; 150(4):805-8. PubMed ID: 26924086 [No Abstract] [Full Text] [Related]
8. Mitigating the risk of post-ERCP pancreatitis: Science and clinical practice. Ang TL J Gastroenterol Hepatol; 2020 May; 35(5):703-704. PubMed ID: 32367564 [No Abstract] [Full Text] [Related]
12. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis. Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176 [TBL] [Abstract][Full Text] [Related]
14. A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction. Siddiqui AA; Patel D; Kaplan J; Zabolotsky AH; Loren D; Kowalski T; Ghumman SS; Adler DG; Munigal S; Hayat U; Eloubeidi MA Dig Dis Sci; 2015 Aug; 60(8):2509-15. PubMed ID: 25868629 [TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs alleviate severity of post-endoscopic retrograde cholangiopancreatography pancreatitis by inhibiting inflammation and reducing apoptosis. Geng C; Li X; Li Y; Song S; Wang C J Gastroenterol Hepatol; 2020 May; 35(5):896-904. PubMed ID: 32064683 [TBL] [Abstract][Full Text] [Related]
16. Role of pancreatic stents in prevention of post-ERCP pancreatitis. Freeman ML JOP; 2004 Sep; 5(5):322-7. PubMed ID: 15365198 [No Abstract] [Full Text] [Related]
17. Prophylactic Effect of Rectal Indomethacin Administration, with and without Intravenous Hydration, on Development of Endoscopic Retrograde Cholangiopancreatography Pancreatitis Episodes: A Randomized Clinical Trial. Hosseini M; Shalchiantabrizi P; Yektaroudy K; Dadgarmoghaddam M; Salari M Arch Iran Med; 2016 Aug; 19(8):538-43. PubMed ID: 27544361 [TBL] [Abstract][Full Text] [Related]
18. Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review. Vadalà di Prampero SF; Faleschini G; Panic N; Bulajic M Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1415-1424. PubMed ID: 27580214 [TBL] [Abstract][Full Text] [Related]
19. Preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: what can be done? Hauser G; Milosevic M; Stimac D; Zerem E; Jovanović P; Blazevic I World J Gastroenterol; 2015 Jan; 21(4):1069-80. PubMed ID: 25632179 [TBL] [Abstract][Full Text] [Related]